| Shareholder | |||
|---|---|---|---|
| 杭州泰格醫藥科技股份有限公司 | 64.09% | 1.30B | |
| Hangzhou Tigermed Consulting Co., Ltd. | 51.45% | 1.03B | |
| 李松Executive Director | 8.72% | 177.54M | |
| Li Song | 8.19% | 169.94M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of FRONTAGE (01521) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

